Company Filing History:
Years Active: 1999
Title: The Innovations of Christopher Robb
Introduction
Christopher Robb is an accomplished inventor based in Galveston, Texas. He has made significant contributions to the field of biotechnology, particularly in the development of non-antibiotic systems for selecting recombinant mycobacteria. His work aims to enhance protective immunity in hosts, showcasing his commitment to advancing medical science.
Latest Patents
Christopher Robb holds a patent for a "Non-antibiotic system for selection of recombinant mycobacteria." This invention provides a Mycobacterium-E. coli shuttle vector that contains sequences coding for a tribrid fusion. The fusion includes the M. leprae 18kDa antigen sequence, a phoA protein antigen sequence, and a non-mycobacterial, non-E. coli heterologous protein antigen sequence. The patent also outlines a method for producing protective immunity in an animal or human host by administering an effective dose of recombinant mycobacteria carrying the vector.
Career Highlights
Robb is affiliated with the University of Texas System, where he continues to engage in innovative research. His work has the potential to impact the field of immunology significantly. With a focus on recombinant mycobacteria, he is at the forefront of developing new therapeutic strategies.
Collaborations
Some of his notable coworkers include Alan D Barrett and David W Niesel. Their collaborative efforts contribute to the advancement of research in biotechnology and immunology.
Conclusion
Christopher Robb's innovative work in the field of biotechnology exemplifies the importance of research in developing new medical treatments. His patent and ongoing contributions reflect a dedication to improving health outcomes through scientific discovery.